These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9303417

  • 1. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Kelley CL, Rouse DA, Morris SL.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2057-8. PubMed ID: 9303417
    [Abstract] [Full Text] [Related]

  • 2. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis.
    Rinder H, Thomschke A, Rüsch-Gerdes S, Bretzel G, Feldmann K, Rifai M, Löscher T.
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):508-11. PubMed ID: 9764555
    [Abstract] [Full Text] [Related]

  • 3. [Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates].
    Wu X, Zhang J, Hu Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):727-9. PubMed ID: 11480074
    [Abstract] [Full Text] [Related]

  • 4. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.
    Sherman DR, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE, Stover CK.
    Science; 1996 Jun 14; 272(5268):1641-3. PubMed ID: 8658136
    [Abstract] [Full Text] [Related]

  • 5. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.
    Heym B, Stavropoulos E, Honoré N, Domenech P, Saint-Joanis B, Wilson TM, Collins DM, Colston MJ, Cole ST.
    Infect Immun; 1997 Apr 14; 65(4):1395-401. PubMed ID: 9119479
    [Abstract] [Full Text] [Related]

  • 6. AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis.
    Sherman DR, Mdluli K, Hickey MJ, Barry CE, Stover CK.
    Biofactors; 1999 Apr 14; 10(2-3):211-7. PubMed ID: 10609885
    [Abstract] [Full Text] [Related]

  • 7. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L, Jiang F, Chen L, Zhao B, Dong J, Sun L, Zhu Y, Liu B, Zhou Y, Yang J, Zhao Y, Jin Q, Zhang X.
    Emerg Microbes Infect; 2018 Nov 16; 7(1):183. PubMed ID: 30446638
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism.
    Baker LV, Brown TJ, Maxwell O, Gibson AL, Fang Z, Yates MD, Drobniewski FA.
    Antimicrob Agents Chemother; 2005 Apr 16; 49(4):1455-64. PubMed ID: 15793126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S, Zakham F, Bertelli C, Merz L, Nicod L, Mazza-Stalder J, Greub G, Jaton K, Opota O.
    Int J Antimicrob Agents; 2020 Aug 16; 56(2):106068. PubMed ID: 32603684
    [Abstract] [Full Text] [Related]

  • 12. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
    Kiepiela P, Bishop KS, Smith AN, Roux L, York DF.
    Tuber Lung Dis; 2000 Aug 16; 80(1):47-56. PubMed ID: 10897383
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Rouse DA, Li Z, Bai GH, Morris SL.
    Antimicrob Agents Chemother; 1995 Nov 16; 39(11):2472-7. PubMed ID: 8585728
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.
    Sreevatsan S, Pan X, Zhang Y, Deretic V, Musser JM.
    Antimicrob Agents Chemother; 1997 Mar 16; 41(3):600-6. PubMed ID: 9056000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.
    Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA.
    Microb Drug Resist; 2008 Dec 16; 14(4):273-9. PubMed ID: 19090721
    [Abstract] [Full Text] [Related]

  • 18. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG.
    Abate G, Hoffner SE, Thomsen VO, Miörner H.
    Eur J Clin Microbiol Infect Dis; 2001 May 16; 20(5):329-33. PubMed ID: 11453593
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.
    Zhang Y, Dhandayuthapani S, Deretic V.
    Proc Natl Acad Sci U S A; 1996 Nov 12; 93(23):13212-6. PubMed ID: 8917570
    [Abstract] [Full Text] [Related]

  • 20. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H, Syre H, Kross M, Stavrum R, Ti T, Phyu S, Grewal HM.
    J Antimicrob Chemother; 2009 Oct 12; 64(4):694-701. PubMed ID: 19710078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.